A 2022 study exploring a vaccine design for pan-Sars-CoV-2 immunity was retracted last month after its lead author, then in Britain, admitted to fabricating data and falsifying images in the paper.
While the retraction of the study, widely cited up until this year by international scientists, marks a significant blow to vaccine research, virologists said the foundational science targeting broader coronavirus immunity remained robust and independent of the retracted study.
Citation records show…
How a retracted UK Covid-19 vaccine study tainted the global hunt for mutation-proof shots

